NCD IMMUNO-PHARMA PRIVATE LIMITED
NCD IMMUNO-PHARMA PRIVATE LIMITED is a Private Limited Company, incorporated under the Companies Act as a Company limited by Shares. It is classified as Non-govt company and is registered at RoC-Kolkata.
There are 2 promoter(s) of the company viz.ARIJIT DAS, SANDIP KUMAR GOSWAMI .
NCD IMMUNO-PHARMA PRIVATE LIMITED Annual General Meeting (AGM) was last held on as per records from the Ministry of Corporate Affairs (MCA).
Financial Details & Insights
The authorized share capital of the company is Rs.10,00,000 and its paid up capital is Rs.4,00,000. Its balance sheet was last filed on None. NCD IMMUNO-PHARMA PRIVATE LIMITED Corporate Identification Number (CIN) is U24231WB2022PTC252589 and its registration number is 252589.
Contact Details & Insights
You can contact them by emailing at ncd.immuno@gmail.com. The companies registered address is 48/7 Purna Das Road Kolkata Kolkata WB 700029 IN.
Other Details & Information
NCD IMMUNO-PHARMA PRIVATE LIMITED's status is Active as per the records. The company is Unlisted.
| CIN | U24231WB2022PTC252589 |
| Company Name | NCD IMMUNO-PHARMA PRIVATE LIMITED |
| ROC Code | RoC-Kolkata |
| Registration Number | 252589 |
| Company Category | Company limited by Shares |
| Company SubCategory | Non-govt company |
| Class of Company | Private |
| Authorised Capital(Rs) | 10,00,000 |
| Paid up Capital(Rs) | 4,00,000 |
| Number of Members (Applicable in case of company without Share Capital) | 0 |
| Date of Incorporation | 29-03-2022 |
| Registered Address | 48/7 Purna Das Road Kolkata Kolkata WB 700029 IN |
| Address other than R/o where all or any books of account and papers are maintained | - |
| Email Id | ncd.immuno@gmail.com |
| Whether Listed or not | Unlisted |
| Suspended at stock exchange | - |
| Date of Last AGM | |
| Date of Balance Sheet | |
| Company Status (for efiling) | Active |
| Last Updated On | 28-05-2022 |
Directors/Signatory Details
| DIN/PAN | Name | Begin Date |
|---|---|---|
| 00837829 | ARIJIT DAS | 29-03-2022 |
| 07359134 | SANDIP KUMAR GOSWAMI | 29-03-2022 |
NCD IMMUNO-PHARMA PRIVATE LIMITED FAQ's
